Global Botulism Treatment Market Size, Status and Forecast 2019-2025

Description

Botulism is a type of poisoning or infection caused by certain bacteria on the preserved food material.
The overall botulism market also provides a detailed analysis of the type and treatment in various regions which includes Americas, Europe, Asia Pacific and Rest of the World. Americas lead the botulism market owing to the largest number of botulism cases every year.
In 2018, the global Botulism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Botulism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Botulism Treatment development in United States, Europe and China.

The key players covered in this study
XOMA (U.S.)
Microbiotix (U.S.)
Valeant Pharmaceuticals (Canada)
Morphotek (U.S.)
Medytox Solutions (U.S.)
Lanzhou Institute of Biological Products (China)
Mentor Corporation and Metabiologics (U.S.)
Merz Pharma (Germany)
Allergan (Irish)
Galderma (Switzerland)

Market segment by Type, the product can be split into
Antitoxin
Antibiotics
Others

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Botulism Treatment status, future forecast, growth opportunity, key market and key players.
To present the Botulism Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Botulism Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Botulism Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Antitoxin
1.4.3 Antibiotics
1.4.4 Others
1.5 Market by Application
1.5.1 Global Botulism Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Botulism Treatment Market Size
2.2 Botulism Treatment Growth Trends by Regions
2.2.1 Botulism Treatment Market Size by Regions (2014-2025)
2.2.2 Botulism Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Botulism Treatment Market Size by Manufacturers
3.1.1 Global Botulism Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Botulism Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Botulism Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Botulism Treatment Key Players Head office and Area Served
3.3 Key Players Botulism Treatment Product/Solution/Service
3.4 Date of Enter into Botulism Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Botulism Treatment Market Size by Type (2014-2019)
4.2 Global Botulism Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Botulism Treatment Market Size (2014-2019)
5.2 Botulism Treatment Key Players in United States
5.3 United States Botulism Treatment Market Size by Type
5.4 United States Botulism Treatment Market Size by Application

6 Europe
6.1 Europe Botulism Treatment Market Size (2014-2019)
6.2 Botulism Treatment Key Players in Europe
6.3 Europe Botulism Treatment Market Size by Type
6.4 Europe Botulism Treatment Market Size by Application

7 China
7.1 China Botulism Treatment Market Size (2014-2019)
7.2 Botulism Treatment Key Players in China
7.3 China Botulism Treatment Market Size by Type
7.4 China Botulism Treatment Market Size by Application

8 Japan
8.1 Japan Botulism Treatment Market Size (2014-2019)
8.2 Botulism Treatment Key Players in Japan
8.3 Japan Botulism Treatment Market Size by Type
8.4 Japan Botulism Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Botulism Treatment Market Size (2014-2019)
9.2 Botulism Treatment Key Players in Southeast Asia
9.3 Southeast Asia Botulism Treatment Market Size by Type
9.4 Southeast Asia Botulism Treatment Market Size by Application

10 India
10.1 India Botulism Treatment Market Size (2014-2019)
10.2 Botulism Treatment Key Players in India
10.3 India Botulism Treatment Market Size by Type
10.4 India Botulism Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Botulism Treatment Market Size (2014-2019)
11.2 Botulism Treatment Key Players in Central & South America
11.3 Central & South America Botulism Treatment Market Size by Type
11.4 Central & South America Botulism Treatment Market Size by Application

12 International Players Profiles
12.1 XOMA (U.S.)
12.1.1 XOMA (U.S.) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Botulism Treatment Introduction
12.1.4 XOMA (U.S.) Revenue in Botulism Treatment Business (2014-2019)
12.1.5 XOMA (U.S.) Recent Development
12.2 Microbiotix (U.S.)
12.2.1 Microbiotix (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Botulism Treatment Introduction
12.2.4 Microbiotix (U.S.) Revenue in Botulism Treatment Business (2014-2019)
12.2.5 Microbiotix (U.S.) Recent Development
12.3 Valeant Pharmaceuticals (Canada)
12.3.1 Valeant Pharmaceuticals (Canada) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Botulism Treatment Introduction
12.3.4 Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2014-2019)
12.3.5 Valeant Pharmaceuticals (Canada) Recent Development
12.4 Morphotek (U.S.)
12.4.1 Morphotek (U.S.) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Botulism Treatment Introduction
12.4.4 Morphotek (U.S.) Revenue in Botulism Treatment Business (2014-2019)
12.4.5 Morphotek (U.S.) Recent Development
12.5 Medytox Solutions (U.S.)
12.5.1 Medytox Solutions (U.S.) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Botulism Treatment Introduction
12.5.4 Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2014-2019)
12.5.5 Medytox Solutions (U.S.) Recent Development
12.6 Lanzhou Institute of Biological Products (China)
12.6.1 Lanzhou Institute of Biological Products (China) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Botulism Treatment Introduction
12.6.4 Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2014-2019)
12.6.5 Lanzhou Institute of Biological Products (China) Recent Development
12.7 Mentor Corporation and Metabiologics (U.S.)
12.7.1 Mentor Corporation and Metabiologics (U.S.) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Botulism Treatment Introduction
12.7.4 Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2014-2019)
12.7.5 Mentor Corporation and Metabiologics (U.S.) Recent Development
12.8 Merz Pharma (Germany)
12.8.1 Merz Pharma (Germany) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Botulism Treatment Introduction
12.8.4 Merz Pharma (Germany) Revenue in Botulism Treatment Business (2014-2019)
12.8.5 Merz Pharma (Germany) Recent Development
12.9 Allergan (Irish)
12.9.1 Allergan (Irish) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Botulism Treatment Introduction
12.9.4 Allergan (Irish) Revenue in Botulism Treatment Business (2014-2019)
12.9.5 Allergan (Irish) Recent Development
12.10 Galderma (Switzerland)
12.10.1 Galderma (Switzerland) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Botulism Treatment Introduction
12.10.4 Galderma (Switzerland) Revenue in Botulism Treatment Business (2014-2019)
12.10.5 Galderma (Switzerland) Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample